There are specific circumstances in which you should seek prompt medical advice, either from your trial team or your GP: Persistent insomnia lasting more than three to four weeks that is significantly affecting your daytime functioning, mood, or concentration Symptoms of anxiety or low mood that have developed or worsened since starting treatment, as these can both cause and be exacerbated by poor sleep Signs of obstructive sleep apnoea such as loud snoring, gasping during sleep (reported by a partner), or excessive daytime sleepiness which require formal assessment and may need referral to a sleep clinic New or worsening palpitations or an irregular heartbeat at night GLP-1-based medicines can be associated with a modest increase in resting heart rate
Wilding J, Batterham RL, Calanna S, et al
Implied FDA approval or review
Be sure to wash the backs of your hands, between your fingers, and under your fingernails
Although these numbers are reason to be concerned, data was pulled from AERS which has potential flaws due to incomplete information and reporting bias